Pharyngitis Market Expansion Plans Focused at Regional Revenue Share during thePosted by Arslan on January 24th, 2019 Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore throat or pharyngitis is caused by viral infection, while around 15-20% is caused by bacterial infection. Hence, throat lozenges are also being prescribed for people suffering from pharyngitis and it also offers temporary relief from cough and cold, which the most common cause of sore throat. As per Randomized Controlled Trial (RCT) published recently in Canadian Medical Association Journal, found that probiotics and xylitol chewing gum have no effect on a sore throat or pharyngitis symptoms. Hence, drug manufacturers are conducting research to develop new drugs to fight sore throat without causing any side-effects. Pharyngitis Market to experience sluggish growth. Towards 2026 end, the global market for pharyngitis is projected to bring in US$ 1,679.0 million revenue. Beta Lactams to Emerge as the Most-Preferred Drug Class Compared to the various drug class, beta lactams is likely to emerge as one of the most preferred drug class between 2017 and 2026. Beta lactams is projected to bring in nearly US$ 500 million revenue by 2026 end. Beta-lactams include cephalosporins and penicillins. These drugs are active against many harmful organisms. Moreover, the recent development of broad-spectrum beta-lactams antibiotics active against gram-negative organisms has increased their Retail Pharmacies and Drug Stores to Emerge as the Biggest Distribution Channel Retail pharmacies and drug stores are likely to gain maximum revenue share. By 2026 end, retail pharmacies and drug stores are projected to bring in nearly US$ 700 million revenue. A sore throat is very common, pharmacists can assess specific symptoms as described by patients and based on it can suggest Over the Counter (OTC) drug that available at retail pharmacies and drug stores. One of the most commonly used OTC products for treating sore throat is lozenges. Moreover, pharmaceutical companies are also introducing new products that can offer rapid relief in pain. Pharyngitis Market Table of Content
3.1. Introduction 3.1.1. Global Pharyngitis Market Taxonomy 3.1.2. Global Pharyngitis Market Definition 3.2. Global Pharyngitis Market Size (US$ Mn) and Forecast, 2012-2026 3.2.1. Global Pharyngitis Market Y-o-Y Growth 3.3. Global Pharyngitis Market Dynamics 3.4. Supply Chain 3.5. Cost Structure 3.6. Pricing Analysis 3.7. Drug Pipeline Assessment 3.8. Product Life Cycle 3.9. PEST Analysis And Continue……… Browse Full Report on Pharyngitis Needle Market with TOC- https://www.factmr.com/report/361/pharyngitis-market The report has also profiled leading players in the global market for pharyngitis, which will remain active through 2026. These include companies such as GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, Zambon Group SpA, and BioStar Pharmaceuticals, Inc.
Like it? Share it! More by this author |